Inserra A

Department of Neurosciences, Imaging and Clinical Sciences, "G. D'Annunzio" University, 66100, Chieti, Italy; Behavioral Neuroscience Laboratory, University of Southern Santa Catarina, Tubarao, Santa Catarina, Brazil.

Inserra A

Dimensional effect profiles in treatment-resistant depression: A naturalistic, prospective head-to-head comparison of arTMS, esketamine nasal spray, and oral brexpiprazole.

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats.

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care.

Single exposure to Ayahuasca reverses chronic stress effects on sociability, anxiety, cortisol, and BDNF in zebrafish.

Potential molecular pathways and therapeutic implications of rapid-acting antidepressants on myelin biology: a scoping review.

Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.

Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.

Ayahuasca reverses ischemic stroke-induced neuroinflammation and oxidative stress.

Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT&lt;sub&gt;2A&lt;/sub&gt; receptor.

Epigenetic mechanisms of rapid-acting antidepressants.

The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics.

Corrigendum: Ceremonial ayahuasca in amazonian retreats-mental health and epigenetic outcomes from a six-month naturalistic study.

Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence.

Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.

Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.

Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.

Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT2A and ampa in the medial prefrontal cortex (MPFC)

Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.

Current status of psychedelic therapy in Australia and New Zealand: Are we falling behind?

Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process.

Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT<sub>2A</sub> receptor.